Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus

被引:37
作者
Fleck, M
Kern, ER
Zhou, T
Podlech, J
Wintersberger, W
Edwards, CK
Mountz, JD
机构
[1] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[2] Univ Regensburg, Dept Med 1, D-93042 Regensburg, Germany
[3] Vet Adm Med Ctr, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA
[5] Johannes Gutenberg Univ Mainz, Dept Virol, D-55101 Mainz, Germany
[6] Amgen Inc, Dept Inflammat, Boulder, CO 80301 USA
关键词
apoptosis; MCMV; Fas; lpr mice; TNF-R1 knockout mice;
D O I
10.1172/JCI3248
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The role of Fas- and TNF-receptor 1 (TNF-R1)-mediated apoptosis in the clearance of virally infected cells and in the regulation of the immune response was analyzed after murine cytomegalovirus (MCMV) infection of C57BL/6 (B6)-+/+ mice, Fas-mutant B6-lpr/lpr mice, TNF-R1 knockout B6-tnfr(0/0) mice, and double-deficient B6-tnfr(0/0) lpr/lpr mice. There was approximately equivalent clearance of MCMV in B6-+/+, B6-tnfr(0/0), and B6-lpr/lpr mice, and by day 28 no infectious virus could be detected in the liver, kidney, lung, or peritoneal exudate. However, delayed virus clearance was observed in B6-tnfr(0/0) lpr/lpr mice. An acute inflammatory response occurred in the liver, lung, and kidney of all mice, which was most severe 7 d after MCMV infection, but resolved by day 28 in B6-+/+ and B6-tnfr(0/0) mice, but not in B6-lpr/lpr or B6-tnfro'o lpr/lpr mice. These results indicate that apoptosis mediated by either Fas or TNF-R1 is sufficient for rapid clearance of the virus. However, apoptosis induced by Fas, but not TNF-R1, is required for the downmodulation of the immune response to the virus and prevention of a chronic inflammatory reaction.
引用
收藏
页码:1431 / 1443
页数:13
相关论文
共 85 条
[51]  
PRICE P, 1993, IMMUNOLOGY, V78, P14
[52]   CYTOTOXIC LYMPHOCYTE-T RESPONSE TO MURINE CYTOMEGALOVIRUS-INFECTION [J].
QUINNAN, GV ;
MANISCHEWITZ, JE ;
ENNIS, FA .
NATURE, 1978, 273 (5663) :541-543
[53]   Analysis of the complete DNA sequence of murine cytomegalovirus [J].
Rawlinson, WD ;
Farrell, HE ;
Barrell, BG .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8833-8849
[54]   THE CONDITIONS OF PRIMARY INFECTION DEFINE THE LOAD OF LATENT VIRAL GENOME IN ORGANS AND THE RISK OF RECURRENT CYTOMEGALOVIRUS DISEASE [J].
REDDEHASE, MJ ;
BALTHESEN, M ;
RAPP, M ;
JONJIC, S ;
PAVIC, I ;
KOSZINOWSKI, UH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :185-193
[55]   PRELIMINARY EVIDENCE FOR IDIOTYPE ANTIIDIOTYPE IMMUNE-COMPLEXES CROSS-REACTIVE WITH LYMPHOCYTE ANTIGENS IN AIDS AND LUPUS [J].
ROOTBERNSTEIN, RS .
MEDICAL HYPOTHESES, 1995, 44 (01) :20-27
[56]   PROTECTION AGAINST FAS-DEPENDENT TH1-MEDIATED APOPTOSIS BY ANTIGEN RECEPTOR ENGAGEMENT IN B-CELLS [J].
ROTHSTEIN, TL ;
WANG, JKM ;
PANKA, DJ ;
FOOTE, LC ;
WANG, ZH ;
STANGER, B ;
CUI, H ;
JU, ST ;
MARSHAKROTHSTEIN, A .
NATURE, 1995, 374 (6518) :163-165
[57]   Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection [J].
Ruzek, MC ;
Miller, AH ;
Opal, SM ;
Pearce, BD ;
Biron, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (07) :1185-1192
[58]   MOUSE CYTOMEGALOVIRUS REACTIVATION IN SEVERE COMBINED IMMUNE-DEFICIENT MICE AFTER IMPLANTATION OF LATENTLY INFECTED SALIVARY-GLAND [J].
SCHMADER, K ;
HENRY, SC ;
RAHIJA, RJ ;
YU, YH ;
DALEY, GG ;
HAMILTON, JD .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (02) :531-534
[59]   A RAPID METHOD FOR MEASURING APOPTOSIS AND DUAL-COLOR IMMUNOFLUORESCENCE BY SINGLE LASER FLOW-CYTOMETRY [J].
SCHMID, I ;
UITTENBOGAART, CH ;
KELD, B ;
GIORGI, JV .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 170 (02) :145-157
[60]   COMPARISON OF THE PATHOGENESIS OF MURINE CYTOMEGALOVIRUS IN LUNG AND LIVER FOLLOWING INTRAPERITONEAL OR INTRATRACHEAL INFECTION [J].
SELGRADE, MK ;
COLLIER, AM ;
SAXTON, L ;
DANIELS, MJ ;
GRAHAM, JA .
JOURNAL OF GENERAL VIROLOGY, 1984, 65 (MAR) :515-523